Tavolixizumab, CAS 1635395-25-3

Product Description: Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Claudia Giampietri, et al. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies. J Transl Med. 2022 Oct 12;20(1):467.

CAS Number: 1635395-25-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99393-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99393-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK